Potential application of neogalactosylalbumin in positron emission tomography evaluation of liver function

Figure 3 Comparison of the [¹⁸F]FNGA positron emission tomography scan parameters between fibrosis mice (n = 10) and control mice (n = 8). A: The LUA was significantly lower in fibrosis liver than that in normal liver; B: The T_p took significantly longer in fibrosis liver to reach a peak than in the normal liver; C: The LUR of fibrosis liver was significantly slower than that of the controls. ^aP < 0.05, ^bP < 0.01 vs fibrosis. [¹⁸F]FNGA: ¹⁸F-labeled neogalactosylalbumin; LUA: Liver uptake capacity; T_p: Peak time; LUR: Liver uptake rate.